AIBD 2016 Conference Review - reviewed by Dr. Jake Begun

In this review:

Pro-inflammatory effects of dietary emulsifiers on the human gut microbiota
Factors predicting loss of response to vedolizumab in IBD
Is there an anti-infliximab antibody threshold to predict infliximab durability?
6-TGN levels correlate with antiinfliximab antibodies in IBD patients
Thiopurine metabolites, adalimumab and anti-adalimumab antibodies
HDWL endoscopy vs HDCE for detection of dysplasia in UC
The impact of IBD nurse navigators on resource utilisation
Adherence to biologic therapies in IBD
Modifiable risk factors for hospital readmission among IBD patients
Does pre-medication reduce the risk of acute infliximab infusion reactions?

Please login below to download this issue (PDF)

Subscribe